Products
Latest Partnered Companies
Projects
Estimated Cost :
Thermo Fisher Scientific to Expand its Capacity of Viral Vector Manufacturing in Plainville, Massach
Thermo Fisher Scientific to Expand its Capacity of Viral Vector Manufacturing in Plainville, Massach
Estimated Cost :
Janssen Pharmaceutical to Expand its R&D Campus at San Francisco, California
Janssen Pharmaceutical to Expand its R&D Campus at San Francisco, California
Estimated Cost :
Aurinia Pharmaceuticals to Establish U.S. Commercial Operations Center in Rockville, Maryland
Aurinia Pharmaceuticals to Establish U.S. Commercial Operations Center in Rockville, Maryland
Estimated Cost :
SCHOTT to Construct New Pharmaceutical Packaging Production Facility in Mullheim, Germany
SCHOTT to Construct New Pharmaceutical Packaging Production Facility in Mullheim, Germany
Press Release
Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate
Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines, and Laboratorios Farmacéuticos Rovi, S.A., a pan-European pharmaceutical company specializing and engaging in the research, development, contract manufacturing and marketing of small molecules and biological specialties, announced a collaboration for large-scale, commercial fill-fi...
Foghorn® Therapeutics Announces Collaboration with Merck to Discover and Develop Novel Oncology Therapeutics Against Transcription Factor Target
Foghorn® Therapeutics Inc., a company advancing an unprecedented class of therapeutics targeting the chromatin regulatory system in oncology, announced that it has entered into a strategic collaboration with Merck, known as MSD outside the United States and Canada. The collaboration will apply Foghorn’s proprietary Gene Traffic Control™ product platform to discover and develop novel therapeutics against a transcription factor target believed to b ...
Regeneron Announces Manufacturing and Supply Agreement for BARDA and U.S. Department of Defense for REGN-COV2 Anti-Viral Antibody Cocktail
Regeneron Pharmaceuticals, Inc. announced that, as part of Operation Warp Speed, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, and the Department of Defense Joint Program
New Nephron-Methapharm Collaboration Improves Health Outcomes for Respiratory Patients
Nephron Pharmaceuticals Corporation, one of the fastest-growing pharmaceuticals companies in the country, today announced a new collaboration with Methapharm. As a part of this collaboration, Nephron will produce kits of methacholine chloride sterile inhalation solution in ready-to-administer
Events
Articles
An Overview - Active Pharmaceutical Ingredient (API)
An Overview - Active Pharmaceutical Ingredient (API)
Next-Generation Biological Therapeutics Discovery & Development
Next-Generation Biological Therapeutics Discovery & Development
AI, Big Data to Have \'Greatest Technology Impact\' in Pharma Industry in 2019
AI, Big Data to Have \'Greatest Technology Impact\' in Pharma Industry in 2019
Dividella’s Monomaterial Packaging Solution to the Global Plastics Crisis
Dividella’s Monomaterial Packaging Solution to the Global Plastics Crisis
6 Incredible Trends Shaping the Future of Pharma Industry
6 Incredible Trends Shaping the Future of Pharma Industry
Expert Talk
Testimonials
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
Advertisements
See your banner here...
